Small Molecules

02 Mar 2007 Insert Therapeutics Signs New Partnership With R&D Biopharmaceuticals
02 Mar 2007 KeyNeurotek AG and Grünenthal GmbH sign exclusive licensing agreement for drug development and marketing
02 Mar 2007 Point Therapeutics Provides Clinical Update
02 Mar 2007 CollaGenex Pharmaceuticals Announces Positive Results of Phase 2 Dose-Finding Study of Incyclinide for the Treatment of Acne
02 Mar 2007 New Data on Investigational Agent TMC278 in Anitretroviral-Naive HIV Patients
02 Mar 2007 Results from Two Phase III Studies on ISENTRESS(TM) (raltegravir, MK-0518), Merck's Oral Investigational Integrase Inhibitor Presented at the Annual Conference on Retroviruses and Opportunistic Infections (CROI)
02 Mar 2007 Preclinical Data From Two Novel Idenix Compounds for the Treatment of HIV Presented at Conference on Retroviruses and Opportunistic Infections (CROI)
02 Mar 2007 Gilead Announces 24-Week Results from Phase II Study of Investigational HIV Integrase Inhibitor GS 9137
01 Mar 2007 Evotec and Interprotein Sign Collaboration Agreement to Develop Interleukin 6 Inhibitors to Treat Inflammatory Diseases
01 Mar 2007 Pharmasset Initiates Multiple Ascending Dose Study of R7128 in Patients Chronically Infected with HCV Genotype 1
01 Mar 2007 Accentia Biopharmaceuticals Acquires Worldwide Exclusive License to Revimmune for All Autoimmune Diseases
01 Mar 2007 AVANIR Pharmaceuticals Summarizes Outcome of FDA Meeting on Zenvia NDA
01 Mar 2007 EPIX Pharmaceuticals Files Formal Appeal for Vasovist(TM) with the Center for Drug Evaluation and Research
01 Mar 2007 Phase III Sativex(R) Data Published in Leading Neurology Journal
01 Mar 2007 Marinus Pharmaceuticals Initiates Phase IIb Study of Ganaxolone for Infantile Spasms
01 Mar 2007 Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin Pulsys NDA
01 Mar 2007 Organon and Acrux to develop contraceptive sprays
28 Feb 2007 Panacos Begins Phase 1 Clinical Study of Second Generation Maturation Inhibitor PA-040
28 Feb 2007 Roche and Kosan to Initiate Phase 2 Cancer Development Program With Epothilone R1645 (KOS-1584)
28 Feb 2007 Par Pharmaceutical Returns PAR-101 Marketing Rights To Optimer Pharmaceuticals
28 Feb 2007 Clinical Update - DEBIO-9902 SR (ZT-1) Implant For Alzheimer's Disease
28 Feb 2007 MAP Pharmaceuticals Reports Positive Phase 2 Results for its Pediatric Asthma Drug Candidate
28 Feb 2007 PPD Licenses Statin from Ranbaxy Laboratories
28 Feb 2007 TargeGen Announces Successful Completion of Phase I Clinical Trial Of Topical AMD Drug TG100801
27 Feb 2007 Novartis committed to making Galvus(R) available for patients with type 2 diabetes after US regulators issue ''approvable letter''

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top